8-K: InfuSystem to Engage Investors at ROTH Conference

InfuSystem Holdings, Inc. announced its CEO and CFO will participate in the 38th Annual ROTH Conference on March 23, 2026, to host one-on-one investor meetings.

Summary

• InfuSystem Holdings, Inc. (NYSE American: INFU) will participate in the 38th Annual ROTH Conference on Monday, March 23, 2026.
• President and Chief Executive Officer, Carrie Lachance, and Chief Financial Officer, Barry Steele, will represent the Company.
• Management is scheduled to host in-person one-on-one meetings with investors throughout the day.
• The conference will be held at The Ritz-Carlton Laguna Niguel in Dana Point, California.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as investor conference participation is a routine but beneficial activity for enhancing corporate visibility and investor engagement, though it does not convey new material operational or financial information.

Positives

• Participation in a prominent investor conference enhances company visibility and engagement with the investment community.
• Opportunity for management to directly communicate the company's strategy and performance to interested investors through one-on-one meetings.

Risks

• Ability to successfully execute on growth initiatives and strategic partnerships.
• Ability to enter into definitive agreements for new business relationships on expected terms or at all.
• Ability to generate estimated potential revenue amounts under new or existing contracts.
• Dependence on estimates of collectible revenue.
• Potential litigation.
• Changes in third-party reimbursement processes.
• Changes in law.
• Global financial conditions and recessionary risks.
• Rising inflation and interest rates.
• Supply chain disruptions.
• Systemic pressures in the banking sector, including disruptions to credit markets.
• Ability to remediate previously disclosed material weakness in internal control over financial reporting.
• Contributions from acquired businesses or new business lines, products or services.

Future Outlook

The filing contains general forward-looking statements regarding the company's ability to execute growth initiatives, enter new business relationships, and generate revenue, but does not provide specific financial guidance or projections related to this event.

Management Comments

• Carrie Lachance, President and Chief Executive Officer, and Barry Steele, Chief Financial Officer, will participate in the 38th Annual ROTH Conference.

Industry Context

StockSavvy.ai notes that participation in investor conferences like the ROTH Conference is a standard practice for publicly traded healthcare service providers. These events are crucial for maintaining investor relations, attracting new capital, and communicating strategic direction within a competitive and evolving healthcare landscape, particularly for companies focused on durable medical equipment and outpatient care.

Comparison to Industry Standards

• This filing is an announcement of an investor relations event and does not contain specific financial or operational results that can be directly compared to industry benchmarks or competitor performance.

Stakeholder Impact

• Shareholders may benefit from increased company visibility and potential for new investor interest.
• Management will engage directly with the investment community, potentially strengthening investor confidence and understanding of the company's strategy.

Next Steps

• Carrie Lachance and Barry Steele will host in-person one-on-one meetings with investors at the 38th Annual ROTH Conference on March 23, 2026.

Key Dates

Recommendation

The filing announces a routine investor relations event, providing no new material financial or operational data to warrant a change in investment recommendation. Investors should monitor for any disclosures made at the conference, but this announcement itself does not alter the fundamental investment thesis.

Keywords

InfuSystem, INFU, ROTH Conference, investor conference, healthcare services, durable medical equipment, patient services, device solutions, oncology, pain management, wound therapy